Trial Profile
Phase III trial of miconazole extended-release muco-adhesive tablets vs miconazole gel for oropharyngeal candidiasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Miconazole (Primary) ; Miconazole (Primary)
- Indications Oropharyngeal candidiasis
- Focus Registrational; Therapeutic Use
- Sponsors Nxera Pharma; Sosei
- 01 Apr 2024 According to a Nxera Pharma Co., Ltd. media release, Sosei Heptares name changed to Nxera Pharma Co., Ltd.
- 12 Feb 2014 New trial record